» Articles » PMID: 21573012

Rapid Dissemination of SIV Follows Multisite Entry After Rectal Inoculation

Overview
Journal PLoS One
Date 2011 May 17
PMID 21573012
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Receptive ano-rectal intercourse is a major cause of HIV infection in men having sex with men and in heterosexuals. Current knowledge of the mechanisms of entry and dissemination during HIV rectal transmission is scarce and does not allow the development of preventive strategies. We investigated the early steps of rectal infection in rhesus macaques inoculated with the pathogenic isolate SIVmac251 and necropsied four hours to nine days later. All macaques were positive for SIV. Control macaques inoculated with heat-inactivated virus were consistently negative for SIV. SIV DNA was detected in the rectum as early as four hours post infection by nested PCR for gag in many laser-microdissected samples of lymphoid aggregates and lamina propria but never in follicle-associated epithelium. Scarce SIV antigen positive cells were observed by immunohistofluorescence in the rectum, among intraepithelial and lamina propria cells as well as in clusters in lymphoid aggregates, four hours post infection and onwards. These cells were T cells and non-T cells that were not epithelial cells, CD68(+) macrophages, DC-SIGN(+) cells or fascin(+) dendritic cells. DC-SIGN(+) cells carried infectious virus. Detection of Env singly spliced mRNA in the mucosa by nested RT-PCR indicated ongoing viral replication. Strikingly, four hours post infection colic lymph nodes were also infected in all macaques as either SIV DNA or infectious virus was recovered. Rapid SIV entry and dissemination is consistent with trans-epithelial transport. Virions appear to cross the follicle-associated epithelium, and also the digestive epithelium. Viral replication could however be more efficient in lymphoid aggregates. The initial sequence of events differs from both vaginal and oral infections, which implies that prevention strategies for rectal transmission will have to be specific. Microbicides will need to protect both digestive and follicle-associated epithelia. Vaccines will need to induce immunity in lymph nodes as well as in the rectum.

Citing Articles

It's all in the gut: the central role of the gut and microbiome in preventing disease progression in simian immunodeficiency viruses infected African nonhuman primates.

Raehtz K, Pandrea I, Apetrei C Curr Opin HIV AIDS. 2025; 20(2):124-132.

PMID: 39774258 PMC: 11802300. DOI: 10.1097/COH.0000000000000911.


Rapid systemic spread and minimal immune responses following SIVsab intrarectal transmission in African green monkeys.

Raehtz K, Xu C, Deleage C, Ma D, Policicchio B, Brocca-Cofano E JCI Insight. 2024; 9(23).

PMID: 39641272 PMC: 11623940. DOI: 10.1172/jci.insight.183751.


So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Kleinman A, Pandrea I, Apetrei C Viruses. 2022; 14(1).

PMID: 35062339 PMC: 8781889. DOI: 10.3390/v14010135.


IL-17A reprograms intestinal epithelial cells to facilitate HIV-1 replication and outgrowth in CD4+ T cells.

Wiche Salinas T, Gosselin A, Raymond Marchand L, Gabriel E, Tastet O, Goulet J iScience. 2021; 24(11):103225.

PMID: 34712922 PMC: 8531570. DOI: 10.1016/j.isci.2021.103225.


Herpes Simplex Virus type 1 infects Langerhans cells and the novel epidermal dendritic cell, Epi-cDC2s, via different entry pathways.

Bertram K, Truong N, Smith J, Kim M, Sandgren K, Feng K PLoS Pathog. 2021; 17(4):e1009536.

PMID: 33905459 PMC: 8104422. DOI: 10.1371/journal.ppat.1009536.


References
1.
Rezza G . Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 17 Suppl 1:S13-6. DOI: 10.1097/00042560-199801001-00005. View

2.
Touloumi G, Pantazis N, Babiker A, Walker S, Katsarou O, Karafoulidou A . Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS. 2004; 18(12):1697-705. DOI: 10.1097/01.aids.0000131395.14339.f5. View

3.
Eskild A, Magnus P, Sohlberg C, Jensen F, Kittelsen P . A comparison of the progression rate to acquired immunodeficiency syndrome between intravenous drug users and homosexual men. Scand J Soc Med. 1994; 22(4):309-14. DOI: 10.1177/140349489402200411. View

4.
Borzy M, CONNELL R, Kiessling A . Detection of human immunodeficiency virus in cell-free seminal fluid. J Acquir Immune Defic Syndr (1988). 1988; 1(5):419-24. View

5.
Galai N, Vlahov D, Margolick J, Chen K, Graham N, Munoz A . Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8(1):66-74. View